Pre Leukemia Treatment the New Findings
Those living with pre leukemia are benefited extremely when longer courses of a gentle form of chemotherapy using decitabine. Pre leukemia, which is now more commonly known as Myelodysplastic Syndrome (MDS) only recently was acknowledged as being a legitimate form of cancer even though it nearly always has led to the development of leukemia.
This study was announced in the journal for the American Cancer Society in which there is an in-depth look at the implications of pre leukemia on the human body.
New Research Revealed
According to researchers, an estimated 45 percent of patients living with pre leukemia and relapse respond to a second course of treatment, but don’t receive the quality and duration in the second response that they did in their initial rounds of chemotherapy. Researchers believe the new finding proves that longer treatments initially may be better in the long-run as opposed to several rounds of therapy.
Found in this study was out of 22 patients 10 had any sort of response that were treated with about three courses of decitabine. Involved were three patients who said to have partial or total response in all of their cell lines, seven patients went through hematologic improvements and a minimum of 50% drop in their requirements from transfusion. The average overall survival rate was reported to be 28 months and decitabine-retreated individuals had only just a 13 month rate of survival after a relapse.
Decitabine retreatment in 12 of the patients not achieving a second response either had no effect or suppressed the abnormal cells without bone marrow repopulation with the normal cells. Out of these 12, four patients went from having pre leukemia to the beginning of acute leukemia.
In conclusion, the authors state how beneficial it is for pre leukemia patients to receive long initial rounds of chemotherapy followed by shorter rounds of maintenance.
What is Pre Leukemia?
Pre leukemia is an illness that influences the bone marrow and causes the dysfunctional red and white blood cells to increase. The cells usually blast and develop from the stem cells while spreading in the blood stream and killing off the normal blood cells. As a result of this abnormal production of blood cells, less red blood cells are formed in order to circulate and carry to the body oxygen.
Those adults in their 50s are commonly effected by pre leukemia and even though therapy is at hand, researchers are trying hard to find a cure. In most cases, patients who have pre leukemia develop blood cell cancer, which is better known as leukemia. As shown in this study, these patients benefit most from this new DNA hypomethylating agent, dectabine,
Do you know someone who is suffering from pre leukemia? If so speak to one of our experienced attorneys at our law firm right away, this way you are guaranteed the legal help and guidance you are entitled to.